Aztreonam FDA Link Generic

A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.

Also Known As:

Az-threonam; Azactam; Azthreonam; SQ-26,776; Urobactam; Az threonam; SQ 26,776; SQ26,776; Propanoic acid, 2- (((1- (2- amino- 4- thiazolyl)- 2- ((2- methyl- 4- oxo- 1- sulfo- 3- azetidinyl)amino)- 2- oxoethylidene)amino)oxy)- 2- methyl- , (2S-(2alpha,3beta(Z)))-

Pharmalogical Action Categories:

Anti-Bacterial Agents

Organic Chemicals: 133
- Amides: 2428
  - Lactams: 2198
    - beta-Lactams: 2386
      - Monobactams: 118
        Aztreonam: 823
- Sulfur Compounds: 278
  - beta-Lactams: 2386
    - Monobactams: 118
      - Aztreonam: 823
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Lactams: 2198
    - Monobactams: 118
      - Aztreonam: 823
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - beta-Lactams: 2386
      - Monobactams: 118
        Aztreonam: 823

SQ 26992

Bio-Agent Context: Research Results